19 April 2016

NICE, 10 Spring Gardens, London

The meeting will start promptly at 10:00 and is expected to finish at approximately 18:00

Please note that this is agenda is subject to change prior to the meeting.

Final Agenda

1. Welcome and introduction to format of meeting

2. Apologies

3. Any other business

4. Minutes from the last Committee meeting held on Tuesday 15 March 2016

5.  Appraisal of nivolumab in combination with ipilimumab for advanced, unresectable melanoma [ID848]

5.1   Declarations of interest - Part 1 only (open session) 

5.2.  Introduction by the Chair, Dr Jane Adam - Part 1 only (open session)                                                                             

5.3.  Presentation by the Lead team, Dr Jeremy Braybrooke, Dr Brian Shine and Miss Pamela Rees - Part 1 AND Part 2 (open and closed session) 

5.4.  Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) - Part 2 only (closed session)

6.     Appraisal of pertuzumab for the neoadjuvant treatment of HER2-positive breast cancer [ID767]

6.1   Declarations of interest - Part 1 only (open session) 

6.2.  Introduction by the Chair, Dr Jane Adam - Part 1 only (open session)                                                                             

6.3.  Presentation by the Lead team, Dr Justin Daniels, Mr Stephen Sharp and Mr David Thomson - Part 1 AND Part 2 (open and closed session) 

6.4.  Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) - Part 2 only (closed session)

7.    Appraisal of talimogene laherparepvec for treating metastatic melanoma [ID508]

7.1   Declarations of interest - Part 1 only (open session) 

7.2.  Introduction by the Chair, Dr Jane Adam - Part 1 only (open session)                                                                             

7.3.  Presentation by the Chair, Dr Jane Adam - Part 1 AND Part 2 (open and closed session) 

7.4.  Agreement on the content of the Final Appraisal Determination (FAD) - Part 2 only (closed session)

 

Date, time and venue of next meeting

Next Technology Appraisal (Committee A) Meeting: Tuesday 17 May 2016, at 10:00am, NICE, 10 Spring Gardens, London, SW1A 2BU.

 To print this agenda, please right click and select ‘Print’ from the menu

To register

You will receive an automated email response when you submit the registration form. If you do not receive this automated response your registration request has not been received, and you will need to complete and submit the registration form again.

 The closing date for registration is Tuesday 05 April 2016. Please note that it may not be possible to accept late registration requests.

 Should you have any queries regarding attending this meeting, please contact the Meetings in Public Coordinator Josh South

Please note that registrants wishing to conduct a research study on the committee meeting and/or NICE processes will require prior permission and should contact NICE Enquiry Handling by email nice@nice.org.uk   Further information about conducting research is also available in our Common Questions and Answers about meetings in public document.

 

 

 

 

Registration period: 21 March 2016 to 05 April 2016
Registration is closed.